Human body fluids have become an indispensable resource for clinical research, diagnosis
and prognosis. Urine is widely used to discover disease-specific glycoprotein biomarkers …

Influenza B virus (IBV) stands as a paradox, often overshadowed by its more notorious
counterpart, influenza A virus (IAV). Yet, it remains a captivating and elusive subject of …

Influenza virus and respiratory syncytial virus cause acute upper and lower respiratory tract
infections, especially in children and the elderly. Early treatment for these infections is …

Background Respiratory tract viral infection is one of the most common and important
diseases in children. Polymerase chain reaction (PCR) tests are often used to detect viruses …

Background Clinical data on patients infected with influenza B Victoria (BV) after the
approval of baloxavir is lacking. Methods This observational study of the Japanese 2023 …

Objectives To investigate the susceptibility of epidemic influenza viruses to neuraminidase
inhibitors (NAIs) and the emergence of resistant viruses after treatment, a prospective …

Although the virological and clinical efficacies of baloxavir for influenza and the post-
treatment emergence of variant viruses have been reported in clinical trials, its efficacies …

To assess the extent of susceptibility to the four neuraminidase inhibitors (NAIs) approved in
Japan of the epidemic viruses in the 2022–23 influenza season in Japan, we measured the …

The duration of fever and symptoms after laninamivir octanoate hydrate (laninamivir)
inhalation were investigated in the Japanese 2016/17 influenza season and the results were …

The H9N2 subtype of avian influenza A viruses (AIV) has spread among domestic poultry
and wild birds worldwide. H9N2 AIV is sporadically transmitted to humans from avian …